Article Information
History
- July 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Flávio Adsuara Cadegiani, MD, PhD1,2,*,
- Ricardo Ariel Zimerman, MD3,
- Daniel do Nascimento Fonseca, MD4,
- Michael do Nascimento Correia, MD5,
- John McCoy, PhD1,
- Carlos Gustavo Wambier, MD, PhD6 and
- Andy Goren, MD1
- 1Applied Biology, Inc. Irvine, CA, USA
- 2Corpometria Institute, Brasilia, Brazil
- 3Hospital da Brigada Militar, Porto Alegre, Brazil
- 4Samel & Oscar Nicolau Hospitals, Manaus, Brazil
- 5Hospital Regional José Mendes, Itacoatiara, Amazonas, Brazil
- 6Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA
- ↵*Corresponding author
: Flavio Adsuara Cadegiani, MD, PhD, Applied Biology, Inc., 17780 Fitch, Irvine, CA 92614, f.cadegiani{at}gmail.com
Posted July 10, 2021.
Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
